Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$ELV Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $6.99 up 15.92% YoY • Reported revenue of $50.44B up 0.70% YoY • Elevance Health raised FY 2026 diluted EPS guidance to at least $22.00, adjusted diluted EPS guidance to at least $29.00, and operating cash flow guidance to at least $6.5B.

Price since post

Full Details

Advertisement|Remove ads.